Want to know more about #radiopharmaceuticals? Check out adMare BioInnovations & CPDC's recent blog about this new class of drugs that have the potential to change the lives of cancer patients - and be a key part of Canadian #lifesciences leading the world. bit.ly/2M8Bw9I

Many thanks to BIV News for sharing the news of our launch...We're excited to make a significant contribution to the BC and Canadian #lifesciences sector; and impact on the lives of #cancer patients. biv.com/article/2021/0… adMare BioInnovations AbCellera Life Sciences BC TRIUMF Innovations

ICYMI: With support from adMare BioInnovations & AbCellera, we launched Abdera: a made-in-Canada precision oncology company developing targeted radiotherapies, a technology with the potential to transform cancer care and save lives. abderatherapeutics.com

Want to know more about the radiopharma landscape in Canada? adMare BioInnovations's recent blog post on #radiopharmaceuticals, in partnership with the Centre for Probe Development and Commercialization, is live now. ⏩ bit.ly/3a9N464

Meet Dr. Lana Janes, our interim CEO. She brings 20+ years of experience in global pharmaceutical development that spans the full life cycle of #TherapeuticProduct development. Learn more about the Abdera team at abderatherapeutics.com

Our technology is a novel targeted alpha therapy (TAT): #NuclearMedicine that selectively destroys cancer cells using antibodies armed with high-energy #radioisotopes that emit alpha particles. Learn more: abderatherapeutics.com

We are grateful to have Canada’s global life sciences venture, adMare BioInnovations, behind us to develop novel #therapeutics for patients with relapsed, refractory and metastatic cancers. Learn more about our partners here: abderatherapeutics.com

Live now at Life Sciences BC's Access to Innovation event is our Venture Partner (and Interim CEO of our spin-off Abdera Therapeutics), Dr. Lana Janes, talking about job #1 at adMare BioInnovations: translating academic research into new Canadian life sciences companies of scale.

Our partner AbCellera is a #TechnologyCompany that searches, decodes, and analyzes natural immune systems to find antibodies. AbCellera’s leading #AntibodyDiscovery platform is key to our technology. Learn more about our partners: abderatherapeutics.com

Meet Dr. Abrams, our Chief Scientific Officer here at Abdera. He brings extensive experience in #biotechnology, #NuclearMedicine and the commercialization of #pharmaceutical products. Learn more about his background at abderatherapeutics.com

A great new initiative from our partners at adMare BioInnovations to bring our national life sciences ecosystem together...

Congratulations to Carl Hansen, CEO of Abdera Therapeutics founding partner AbCellera - along with the other finalists on this very well-deserved honour!

Our CEO Lana Janes is participating this Thursday on @UBCmedicine Career Day. She will be part of a panel about insights from #biotech CEO’s on making the transition to industry and tell her story to students who are aiming at a career in #lifesciences. vchri.ca/careerday-reg